Migraines
Comprehensive integrative medicine approach for lasting healing and complete recovery
Understanding Migraines
Migraine is a complex neurological disorder characterized by recurrent, severe headaches lasting 4-72 hours, often accompanied by nausea, extreme sensitivity to light (photophobia), and sound (phonophobia). It involves dysregulation of the trigeminovascular system, cortical spreading depression (CSD), and elevated calcitonin gene-related peptide (CGRP) levels. Migraine with aura includes transient neurological symptoms preceding the headache, while migraine without aura presents with headache as the initial symptom.
Recognizing Migraines
Common symptoms and warning signs to look for
Throbbing or pulsing headache pain, typically on one side of the head
Extreme sensitivity to light (photophobia) and sound (phonophobia) during attacks
Nausea and vomiting during migraine episodes
Visual disturbances or sensory aura preceding headache (flashing lights, blind spots, tingling)
Pain worsens with physical activity and prevents normal daily function
What a Healthy System Looks Like
In a healthy individual, the trigeminal nerve operates without inappropriate activation, with pain processing centers in the thalamus, brainstem nuclei, and cortex effectively filtering incoming signals. Cerebral blood flow remains stable through precise autoregulation, and serotonin (5-HT) signaling pathways function optimally to modulate pain perception and vascular tone. The hypothalamus maintains hormonal balance, and cortical electrical activity spreads normally without triggering pathological waves of depolarization. The trigeminovascular system remains in a quiescent state, with CGRP released only during normal neurovascular responses.
How the Condition Develops
Understanding the biological mechanisms
Migraine involves multiple interconnected neurological mechanisms: (1) Cortical Spreading Depression (CSD) - a wave of neuronal depolarization followed by suppression of activity that spreads across the cerebral cortex at 2-3mm per minute, causing aura symptoms; (2) Trigeminovascular System Activation - trigeminal nerve endings release neuropeptides including CGRP, causing neurogenic inflammation and vasodilation of meningeal blood vessels; (3) Serotonin Dysfunction - altered 5-HT1B/1D receptor signaling affects pain modulation and cranial vessel tone; (4) Brainstem Nuclei Activation - the trigeminal cervical complex, locus coeruleus, and dorsal raphe nuclei become hyperactive, amplifying pain signals; (5) Thalamic Pain Pathway Dysregulation - third-order neurons in the thalamus demonstrate increased sensitivity and central sensitization; (6) Hypothalamic Involvement - premonitory symptoms like yawning, mood changes, and food cravings originate from hypothalamic dysfunction; (7) CGRP Release - elevated CGRP during attacks causes meningeal vasodilation, plasma extravasation, and peripheral sensitization of trigeminal nociceptors.
Key Laboratory Markers
Important values for diagnosis and monitoring
| Test | Normal Range | Optimal | Significance |
|---|---|---|---|
| CGRP (Calcitonin Gene-Related Peptide) | <50 pg/mL | <25 pg/mL | Elevated CGRP during attacks causes vasodilation and neurogenic inflammation; key target for migraine-specific medications (gepants, monoclonal antibodies) |
| Serotonin (5-HT) | 50-200 ng/mL | 100-150 ng/mL | Altered serotonin metabolism is central to migraine pathogenesis; affects pain modulation and vascular tone |
| CRP (C-Reactive Protein) | <3 mg/L | <0.5 mg/L | Markers of systemic inflammation; elevated levels may indicate chronic inflammation contributing to migraine pathophysiology |
| Estradiol (E2) | 30-400 pg/mL (varies by cycle) | 80-150 pg/mL (mid-follicular) | Hormonal fluctuations in estrogen are major migraine triggers; stable levels reduce attack frequency |
| Homocysteine | 5-15 micromol/L | <8 micromol/L | Elevated homocysteine associated with increased migraine with aura risk and cardiovascular complications |
| Magnesium (Serum) | 1.5-2.5 mg/dL | 2.0-2.5 mg/dL | Magnesium deficiency is common in migraine sufferers; essential for preventing cortical spreading depression |
Root Causes We Address
The underlying factors contributing to your condition
{"cause":"Genetic Predisposition","contribution":"40%","assessment":"Family history (2-4x increased risk); genetic testing for MTHFR, COMT, and serotonin transporter genes"}
{"cause":"CGRP Pathway Dysfunction","contribution":"30%","assessment":"CGRP levels during and between attacks; response to CGRP monoclonal antibodies or gepants"}
{"cause":"Hormonal Influences","contribution":"35%","assessment":"Hormone panel throughout cycle; symptom tracking relative to menstrual cycle, perimenopause, or contraceptive use"}
{"cause":"Environmental and Dietary Triggers","contribution":"30%","assessment":"Detailed trigger diary; elimination diet; tracking apps; common triggers include aged cheeses, processed meats, MSG, alcohol, caffeine"}
{"cause":"Serotonin Dysregulation","contribution":"25%","assessment":"Serotonin levels, platelet 5-HT content, genetic testing for serotonin-related genes"}
{"cause":"Stress and HPA Axis Dysregulation","contribution":"25%","assessment":"Cortisol levels (salivary four-point test), DHEA-S, ACTH, stress history"}
{"cause":"Gut-Brain Axis Dysfunction","contribution":"20%","assessment":"Stool microbiome analysis, food sensitivity testing, leaky gut markers (zonulin)"}
Risks of Inaction
What happens if left untreated
{"complication":"Chronic Daily Headache Transformation","timeline":"Months to years","impact":"Medication overuse develops into chronic daily headache; 15+ headache days per month becomes new baseline"}
{"complication":"Medication Overuse Headache (MOH)","timeline":"Ongoing with regular analgesic use","impact":"Rebound headaches from frequent use of triptans, NSAIDs, or analgesics; treatment requires withdrawal"}
{"complication":"Cardiovascular Complications","timeline":"Years, especially with migraine with aura","impact":"Increased risk of stroke (2-3x), cardiovascular disease, hypertension; prothrombotic state"}
{"complication":"Mental Health Impact","timeline":"Progressive","impact":"Chronic migraine increases depression risk 2-3x, anxiety disorders, suicide risk; chronic pain creates learned helplessness"}
{"complication":"Cognitive Decline","timeline":"Progressive with chronic migraine","impact":"Persistent brain fog, memory issues, decreased executive function; MRI shows grey matter changes in pain processing areas"}
How We Diagnose
Comprehensive assessment methods we use
{"test":"Comprehensive Blood Panel","purpose":"Rule out underlying conditions and assess contributing factors","whatItShows":"CBC, CMP, CRP, ESR, TSH, Free T3/T4, estradiol, progesterone, testosterone, cortisol, homocysteine, vitamin D, B12, magnesium"}
{"test":"CGRP Level Testing","purpose":"Confirm CGRP-mediated mechanism and guide targeted therapy","whatItShows":"Calcitonin gene-related peptide levels during and between attacks"}
{"test":"Serotonin Panel","purpose":"Assess serotonin metabolism and function","whatItShows":"Serotonin levels, 5-HIAA (metabolite), platelet 5-HT content"}
{"test":"Food Sensitivity Panel","purpose":"Identify dietary triggers","whatItShows":"IgG/IgA reactions to common migraine-trigger foods (aged cheeses, processed meats, MSG, gluten)"}
{"test":"Genetic Testing (MTHFR, COMT)","purpose":"Identify genetic factors affecting methylation and neurotransmitter metabolism","whatItShows":"MTHFR C677T mutation, COMT variants, serotonin transporter gene (5-HTTLPR)"}
{"test":"MRI/MRA Brain","purpose":"Rule out structural causes and assess for complications","whatItShows":"Structural abnormalities, vascular malformations, white matter changes, Chiari malformation"}
Our Treatment Approach
How we help you overcome Migraines
Phase 1: Stabilization and Acute Management (Weeks 1-4)
{"phase":"Phase 1: Stabilization and Acute Management (Weeks 1-4)","focus":"Establish baseline, identify triggers, and optimize acute attack treatment","interventions":"Comprehensive history and migraine chronification assessment. Advanced laboratory testing (CGRP, serotonin, hormones, inflammatory markers). Trigger diary initiation. Optimize acute medications (triptans, gepants, NSAIDs). Begin magnesium and riboflavin supplementation. Stress management initiation (biofeedback, meditation). Baseline all labs before treatment.\n"}
Phase 2: Root Cause Correction (Weeks 4-12)
{"phase":"Phase 2: Root Cause Correction (Weeks 4-12)","focus":"Address underlying mechanisms to prevent future attacks","interventions":"Implement CGRP-targeted therapy (monoclonal antibodies or receptor antagonists if indicated). Anti-inflammatory dietary modifications (eliminate triggers: tyramine, MSG, nitrates). Hormonal optimization if indicated. Gut healing protocol if leaky gut identified. Methylation support if MTHFR mutation present. Structural correction (cervical physiotherapy, TMJ treatment if indicated). Continue stress management techniques.\n"}
Phase 3: Optimization and Maintenance (Months 4-6)
{"phase":"Phase 3: Optimization and Maintenance (Months 4-6)","focus":"Sustain improvements and prevent relapse","interventions":"Personalized maintenance protocol based on response. Continued trigger management and lifestyle modifications. Stress resilience building. Regular monitoring and adjustment of supplements. Progressive return to normal activities. Emergency protocol for breakthrough attacks established. Many patients achieve 50%+ reduction in attack frequency.\n"}
Phase 4: Long-Term Management (Month 6+)
{"phase":"Phase 4: Long-Term Management (Month 6+)","focus":"Maintain optimal function and prevent recurrence","interventions":"Ongoing monitoring (quarterly). Lifestyle maintenance (sleep, diet, exercise, stress). Annual review of treatment protocol. Focus on prevention of medication overuse. Address any new triggers or comorbidities. Most patients maintain 80-100% improvement with sustained protocol adherence.\n"}
Diet & Lifestyle
Recommendations for optimal recovery
Lifestyle Modifications
Consistent sleep schedule: 7-9 hours nightly at regular times, Stress management: meditation, yoga, mindfulness daily, Regular moderate exercise: 30 minutes most days, Trigger identification and systematic avoidance, Screen time management: blue light filters, regular breaks, Posture correction: ergonomic workspace setup, Cervical spine care: proper pillow, regular stretching, Biofeedback therapy: proven non-pharmacological intervention, Cognitive behavioral therapy: addresses pain perception and coping, Journaling: track triggers, symptoms, and patterns
Recovery Timeline
What to expect on your healing journey
Phase 1 (Weeks 1-4): Initial stabilization with trigger identification; baseline labs established; acute medication optimization; beginning supplementation (magnesium, riboflavin); some patients notice reduced attack severity.
Phase 2 (Weeks 4-12): Root cause correction intensifies; CGRP-targeted therapy if indicated; dietary modifications; hormonal optimization if needed; gut healing protocols; 30-50% reduction in attack frequency typical.
Phase 3 (Months 4-6): Continued optimization based on response; lifestyle modifications entrenched; most patients achieve 50%+ reduction in migraine days; improved quality of life and functional capacity.
Phase 4 (Month 6+): Maintenance phase; regular monitoring; lifestyle maintenance; patients typically achieve 70-90% improvement with comprehensive protocol adherence; breakthrough attacks managed with emergency protocols.
How We Measure Success
Outcomes that matter
Reduction in monthly migraine days (target: 50%+ decrease)
Decreased attack severity (average pain score reduction from 8-10 to 3-4)
Improved response to acute medications
Resolution of aura symptoms
Reduced allodynia and central sensitization
Improved quality of life scores
Reduced medication use/overuse
Normalized CGRP levels
Improved hormonal balance
Better sleep quality and stress resilience
Frequently Asked Questions
Common questions from patients
What is the difference between migraine with aura and migraine without aura?
Migraine with aura includes transient neurological symptoms that precede or accompany the headache, such as visual disturbances (flashing lights, blind spots), sensory changes (tingling, numbness), or speech difficulties. These symptoms typically develop over 5-20 minutes and last less than 60 minutes. Migraine without aura presents directly with headache symptoms without preceding neurological manifestations. Both types can be equally disabling and share similar treatment approaches.
How do CGRP medications work for migraines?
CGRP (calcitonin gene-related peptide) is a neuropeptide released during migraine attacks that causes vasodilation of meningeal blood vessels and triggers neurogenic inflammation. CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) bind to either the CGRP receptor or the peptide itself to prevent attacks. Gepants (ubrogepant, rimegepant, atogepant) are oral CGRP receptor antagonists that can both prevent and treat acute attacks. These represent the first medications specifically designed for migraine pathophysiology.
What foods commonly trigger migraines?
Common dietary triggers include: aged cheeses and fermented foods (tyramine), processed meats with nitrates/nitrites, monosodium glutamate (MSG), alcohol especially red wine and beer, excessive caffeine or caffeine withdrawal, artificial sweeteners especially aspartame, and gluten in sensitive individuals. Individual triggers vary significantly, making a detailed food and symptom diary essential for identification. Skipping meals and dehydration are also common triggers affecting many migraine sufferers.
Can hormonal changes trigger migraines?
Yes, hormonal fluctuations are a major migraine trigger, particularly estrogen fluctuations. Many women experience menstrual migraines occurring 2 days before to 3 days after menstruation when estrogen levels drop sharply. Perimenopausal migraines often worsen due to erratic estrogen levels. Certain contraceptives containing estrogen can trigger or worsen migraines, while some women improve with stable hormonal states. Pregnancy may improve migraines in some women but worsen them in others. Estrogen affects serotonin signaling, CGRP expression, and cortical excitability, making hormonal management an important treatment consideration.
When should I seek emergency care for a migraine?
Seek emergency care if you experience: the worst headache of your life, headache with fever and stiff neck (possible meningitis), headache after head injury, headache with confusion or loss of consciousness, new headache after age 50, headache with seizures, or headache with weakness or numbness. Also seek emergency care if: aura symptoms last longer than 60 minutes, you experience first-ever aura at any age (could indicate stroke), or headache does not respond to usual treatments. These could indicate serious conditions requiring immediate intervention.
Medical References
- 1.Goadsby PJ, Holland PR, Martins-Oliveira M, et al. Pathophysiology of Migraine: A Clinical Review. Headache. 2017;57(5):765-778. doi:10.1111/head.13096. PMID: 28444105
- 2.Ashina M. Migraine. N Engl J Med. 2020;383(19):1866-1876. doi:10.1056/NEJMra1915327. PMID: 33211930
- 3.Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018;17(2):174-181. doi:10.1016/S1474-4422(17)30435-0. PMID: 29306511
Ready to Start Your Healing Journey?
Our integrative medicine experts are ready to help you overcome Migraines.